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Abstract
Background: To the best of our knowledge, no study has compared gram-negative bacillary hematogenous
pyogenic spondylodiscitis (GNB-HPS) with gram-positive coccal hematogenous pyogenic spondylodiscitis (GPC-HPS)
regarding their clinical characteristics and outcomes.
Methods: From January 2003 to January 2013, 54 patients who underwent combined antibiotic and surgical therapy
in the treatment of hematogenous pyogenic spondylodiscitis were included.
Results: Compared with 37 GPC-HPS patients, the 17 GNB-HPS patients were more often found to be older individuals,
a history of cancer, and a previous history of symptomatic urinary tract infection. They also had a less incidence of
epidural abscess formation compared with GPC-HPS patients from findings on magnetic resonance imaging (MRI).
Constitutional symptoms were the primary reasons for initial physician visits in GNB-HPS patients whereas pain in the
affected spinal region was the most common manifestation in GPC-HPS patients at initial visit. The clinical outcomes
of GNB-HPS patients under combined surgical and antibiotic treatment were not different from those of GPC-HPS
patients. In multivariate analysis, independent predicting risk factors for GNB-HPS included a malignant history and
constitutional symptoms and that for GPC-HPS was epidural abscess.
Conclusions: The clinical manifestations and MRI presentations of GNB-HPS were distinguishable from those of
GPC-HPS.
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Background
Hematogenous pyogenic spondylodiscitis (HPS) is an
infection involving the intervertebral disc and adjacent
vertebrae that occurs by hematogenous spread of bac-
teria from a distant site. HPS is highly associated with
diabetes mellitus, infective endocarditis, chronic kidney
disease, cancer, immunosuppressive disorders, and intra-
venous drug abuse. The prevalence of HPS is more
frequent in males and the elderly [1, 2]. The main
causative microorganisms include gram-positive cocci
(GPC), especially Staphylococcus aureus, which account
for 40-60% of HPS patients [2, 3], and gram-negative
bacilli (GNB) which constitute 15–23% of cases [2, 4].
Despite the significant incidence of HPS caused by GNB,
few studies in the literature are concerned with the
clinical characteristics and outcomes of hematogenous
spinal infections caused by GNB [5, 6].
To the best of our knowledge, no reports have com-
pared the clinical characteristics and outcomes of HPS
caused by GNB vs. GPC. The goal of this study was to
evaluate clinical presentations, past infectious histories,
imaging findings, and clinical outcomes in GNB-HPS vs.
GPC-HPS patients.
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From January 2003 to January 2013, a retrospective review
of 54 patients with HPS was performed using the Spine
Operation Registry of our institution. All patients included
in this study underwent combined antibiotic and surgical
treatment. The indications for surgical treatment included
poor response to antibiotic therapy, worsening neurologic
impairment, epidural abscess formation, and/or significant
osseous destruction with spinal instability. Surgical ap-
proaches included anterior or posterior spinal surgery, or
combined anterior and posterior approaches. Because the
clinical and radiological presentations differed among the
patients (Figs. 1 and 2), the surgical approach was chosen
based on the individual patient’s presentation, i.e., the level
of the involved vertebrae, the extent of osseous destruc-
tion, and the presence or absence of an abscess and its
location, if present.
All HPS patients received a 3-month course of antibiotic
therapy which consisted of at minimum 2 week course of
parenteral antibiotics based on culture results. Outpatient
oral antibiotic treatment completed a 3 month course of
antibiotics after normalization of serum C-reactive protein
(CRP) levels and leukocyte counts. Patients who survived
were followed-up for a minimum of 2 years.
Pyogenic spondylodiscitis was defined as a spinal in-
fection encompassing both vertebral osteomyelitis and
discitis [7]. The definitive diagnosis of pyogenic spondy-
lodiscitis was based on clinical presentation, imaging
findings from plain radiographs and contrast-enhanced
magnetic resonance imaging (MRI), and intraoperative
bacteriologic cultures [4]. Exclusion criteria were: (1)
negative microbiological culture from the infected speci-
men; (2) non-pyogenic infection; (3) surgical site infection
associated with spine surgery and percutaneous spinal
procedures including epidural steroid injection, selective
nerve root block, and radiofrequency ablation; (4) history
of previous spinal surgery on any level; and (5) history of a
bedsore or penetrating wound on the back.
Data assessment
In order to compare the clinical manifestations and out-
comes between GNB-HPS and GPC-HPS patients, patient
characteristics, underlying comorbidities, bacteriologic re-
sults, MRI findings, and final outcomes were reviewed
using the electronic database at our hospital. The imaging
findings were reviewed independently by two spine sur-
geons (CCC, and YYL) who were unaware of the culture
results. For a history of an infectious disease, the patient
sustained an infectious disease before pyogenic spondylo-
discitis and received antimicrobial therapy. The history of
symptomatic urinary tract infection (UTI) would be
recorded when a patient was admitted for parenteral
antibiotics therapy to treat cultured-proved urinary
tract infection. The history of infectious diseases has
been completely recorded and reviewed in every pa-
tient’s electronic chart.
A one-level spinal infection was defined as an infec-
tion involving two contiguous vertebral bodies and one
adjacent intervertebral disc, and a two-level spinal infec-
tion was involving three contiguous vertebral bodies and
two adjacent discs.
A spinal epidural abscess (Fig. 3) was defined as an
epidural mass with iso-or hypointensity on T1-weighted
Fig. 1 Escherichia coli infectious spondylodiscitis of L3-4 in a patient with a past history of colon cancer (a). Disc space was narrowing with
nearby destructed endplates on L3-4 level; b Osteomyelitis in L3-4 vertebral bodies, discitis and psoas abscess without epidural abscess were
found in gadolinium-enhanced magnetic resonance imaging; c Anterior and posterior spinal surgery was noticed in the immediate postoperative
X-ray.; d and e Solid bone fusion was noticed at the 2-year follow-up
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images, hyperintensity on T2-weighted images and linear
enhancement surrounding non-enhancing purulent or
necrotic matter on MRI [8].
To assess clinical outcomes following combined anti-
biotic and surgical treatment, delayed wound healing
was defined as prolonged wound exudate, or persistent
fever with erythematous wound two weeks after admin-
istration of antibiotics and surgical treatment, relapsing
infection was defined as recurrent spinal infection within
1 year after resolution of infection at hospital discharge.
Mortality was defined as death owing to progressive
sepsis or medical complications.
Statistical methods
Univariate analysis was used to determine factors asso-
ciated with GNB-HPS and GPC-HPS. An independent
student t test was used for numerical data. A χ2 ana-
lysis or a Fisher’s exact test was used for categorical
data. Descriptive data were presented as the mean with
standard deviation for quantitative variables and as fre-
quency for categorical variables. Statistical significance
was set at a p-value of < 0.05. Multivariate analysis was
used to determine independent predicting factors associ-
ated with GNB-HPS and GPC-HPS. All factors showing
statistical significance (p-value of <0.05) in univariate ana-
lysis were incorporated in multivariate logistic regression
analysis. Statistical analyses were performed using the




A total of 54 HPS patients included 17 GNB-HPS pa-
tients and 37 GPC-HPS patients (Table 1). The average
follow-up period was 4.5 years (range, 2–6 years). GNB-
HPS patients were significantly older than GPC-HPS pa-
tients (mean age, 65 vs. 55 years, respectively; p = 0.014).
With regards to symptoms at initial visit, only back
pain predominated in GPC-HPS (73%) compared with
GNB-HPS patients (30%), and the prevalence of consti-
tutional symptoms (fever or drowsiness) with/without
back pain were more frequent in GNB-HPS patients
(70% vs. 27%, p = 0.003). The average duration of symp-
toms in GNB-HPS vs. GPC-HPS patients were 18 vs.
37 days, respectively (p = 0.162).
Seven of 17 GNB-HPS patients had a history of malig-
nancy, including three colorectal cancer patients, one
cervical cancer patent, one lung cancer patient, one
breast cancer patient, and one bladder cancer patient.
One GPC-HPS patient had a history of hypopharyngeal
cancer. A history of malignancy was more commonly
represented in GNB-HPS compared with GPC-HPS
patients (41% vs. 3%, respectively; p < 0.001).
Delayed wound healing was found in eight patients
(one patient with GNB infection and seven patients with
GPC infection); relapse of infection occurred in eleven
patients (one patient with GNB infection and ten pa-
tients with GPC infection); eight deaths occurred in the
HPS patients including three deaths in GNB-HPS
Fig. 2 Hematogenous Pyogenic Spondylodiscitis of L4-5 due to methicillin-resistant Staphylococcus aureus infections (a). Narrowing disc space
with endplate erosion with pigtail catheter placement for drainage of paravertebral abscess was noticed on L4-5 level; b Abscess formation was
found in ventral epidural space, bilateral psoas and back muscles; c Supplementary posterior spinal instrumentation was performed 6 weeks after
anterior debridement and a tricortical iliac strut bone graft for intervertebral fusion; d and e Solid bone fusion on L4-5 was noticed at the
1-year follow-up
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patients and five deaths in GPC-HPS patients. Among
the eight deaths, six patients died of uncontrolled infec-
tion, and two patients died of comorbidities within
3 months after hospital discharge (one from liver cirrho-
sis (Child-Pugh Class B) and upper gastrointestinal
bleeding, and one from complicated pneumonia). All ten
patients with relapsing infection had successful reso-
lution of infection after a second surgical debridement
and completion of antibiotic therapy. There were no sig-
nificant differences in relapse of infection or mortality
between GNB-HPS and GPC-HPS patients. All of
survival patients with eradication of infection had solid
fusion in spondylodiscitis at the final radiographic
follow-up (p = 0.696).
History of infectious disease
Twenty-three (43%) of 54 patients had histories of previ-
ous infections, including 7 (41%) GNB-HPS patients and
16 (43%) GPC-HPS patients (Table 2). GNB-HPS pa-
tients had a significantly higher frequency of previous
symptomatic UTI compared with GPC-HPS patients (41%
vs. 3%, respectively; p = 0.03). There was no significant
difference in histories of other infectious disorders.
Microbiologic findings
The microbiologic results from infected intraoperative
specimens in the 54 HPS patients are outlined in Table 3.
Among the GNB-HPS patients, Escherichia coli was the
most commonly isolated pathogen, involved six patients
(35%), followed by Enterobacter cloacae in four (24%)
patients, Klebsiella pneumonia in two (12%) patients,
Salmonella enteric in two (12%) patients, Pseudomonas
aeruginosa in two patients (12%), Proteus mirabilis in
one (6%) patient, and Citrobacter freundii in one (6%)
patient. For GPC-HPS, Staphylococcus aureus was the
most common isolate (86%). The other isolated GPC
pathogens were Coagulase-negative staphylococcus (14%),
and Streptococcus sp. (8%). All organisms cultured from
intraoperative infected specimens were the same as those
obtained from earlier blood cultures.
Fig. 3 Elucidation of epidural abscess and muscle abscess in contrast-enhanced magnetic resonance imaging with fat suppression among
9 g-positive pyogenic spondylodiscitis (a–c). The spinal epidural abscess was defined as an epidural mass with iso-or hypointensity on T1-weighted
images, which was surrounded by linear enhancement (ring sign) on magnetic resonance imaging. Abscess formation in psoas muscle or back muscle
was defined as an asymmetrical enlarged mass of the involved muscle with ring sign on magnetic resonance imaging. d–f Ventral epidural abscess was
noticed on sagittal gadolinium-enhanced fat-suppressed T1-weighted magnetic resonance
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Findings of magnetic resonance imaging
The MRI results showed that GNB-HPS patients had a
significantly lower rate of epidural abscess compared
with GPC-HPS patients (41% vs. 73%, p = 0.024) (Table 4).
Table 1 Characteristics of 54patients with hematogenous
pyogenic spondylodiscitis
variable GNB (n = 17) GPC (n = 37) p
Age (yr) 65 ± 14.2 55 ± 14.5 0.014*
Male sex (No. [%]) 11 (65) 31 (84) 0.162
Follow-up (yr) 4.8 (2–6) 4.4 (2–6) 0.372
Affected level (No. [%])
1 14 (82) 28 (76) 0.732
2 3 (18) 9 (24)
Location of spinal lesions (No. [%])
Cervical spine 0 2 (5) 0.601
Thoracic spine 2 (12) 5 (14)
Lumbosacral spine 15 (88) 30 (81)
Symptoms at the initial visit (No. [%])
Back/neck pain only 5 (30) 27 (73) 0.003*
Constitutional symptoms only 6 (35) 2 (5)
Back pain with constitutional
symptoms
6 (35) 8 (22)
Duration of symptoms (day) 18 ± 21.8 37 ± 51.6 0.162
Comorbidity (No. [%])
Diabetes mellitus 4 (24) 18 (49) 0.135
End stage renal failure with
hemodialysis
0 5 (30) 0.168
Chronic liver disease 6 (35) 12 (32) 0.824
Malignancy 7 (41) 1 (3) <0.001*
Intravenous drug abuse 0 6 (16) 0.161
Neurologic symptoms (No. [%]) 12 (71) 22 (59) 0.432
Radicular pain 9 (53) 13 (35)
Limb weakness 7 (41) 11 (30)
Cauda equina syndrome 2 (12) 3 (8)
Type of surgery (No. [%])
Anterior surgery 6 (35) 16 (43) 0.846
Posterior surgery 7 (41) 7 (19)
Combined surgery 4 (24) 14 (38)
Clinical outcome (No. [%])
Delayed wound healing 1 (6) 7 (19) 0.411
Relapse 1 (6) 10 (27) 0.143
Death 3 (18) 5 (14) 0.7
Radiologic result (No. [%])
Solid fusion 14 (82) 32 (86) 0.696
Segmental instability 0 0
Data are presented as the mean ± standard deviation or frequency (%),
*The difference is significant (p < 0.05), GNB gram-negative bacilli,
GPC gram-positive cocci







History of infectious disease (No. [%]) 7 (41) 16 (43) 0.887
Musculoskeletal infection (No. [%]) 2 (12) 11 (30) 0.189
Cellulitis 2 (12) 4 (11)
Necrotizing fasciitis 0 5 (14)
Osteomyelitis 0 2 (5)
Symptomatic urinary tract infection
(No. [%])
4 (41) 1 (3) 0.03*
Miscellaneous (No. [%])
Pneumonia 1 (6) 1 (3)
Port-A catheter infection 1 (6) 1 (3)
Liver abscess 1 (6) 0
Infective endocarditis 0 1 (3)
Periorbital abscess 1 (6) 0
AV shunt infection 0 2 (5)
*The difference is significant (p < 0.05), GNB-HPS gram-negative bacillary
hematogenous pyogenic spondylodiscitis, GPC-HPS gram-positive coccal
hematogenous pyogenic spondylodiscitis
Table 3 Microbiologic findings
Microorganism GNB (n = 17)
Monomicrobial (No. [%])
Escherichia coli 5 (29)
Enterobacter cloacae 4 (24)
ESBL 1 (6)
Klebsiella pneumonia 2 (12)
Salmonella enteric 2 (12)
Pseudomonas aeruginosa 1 (6)
Proteus mirabilis 1 (6)
Citrob.freundii 1 (6)
Polymicrobial
Ps. aeruginosa + E.coli (ESBL) 1 (6)





Coag(−) staphylococcus 2 (5)
Streptococcus:
Group B Streptococcus 2 (5)
Streptococcus viridans 1 (3)
Polymicrobial
CoNS, MSSA 1 (3)
CoNS, MRSA 2 (5)
ESBL Extended-spectrum β–lactamase, MSSA methicillin-sensitive Staphylococcus
aureus, MRSA methicillin-resistant Staphylococcus aureus, CoNS Coag(−)
staphylococcus
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There were no significant differences in the incidence of
psoas muscle abscess or back muscle abscess between
GNB-HPS and GPC-HPS patients.
Laboratory presentations
There was no statistically difference in laboratory pa-
rameters between two group patients, even higher aver-
age levels of CRP and erythrocyte sedimentation rates in
GPC-HPS patients (p = 0.061 and 0.076, respectively)
(Table 5). Microbial pathogens were isolated from the
blood cultures of eight GNB-HPS patients and 23 GPC-
HPS patients (47% vs. 62%, p = 0.297).
Multivariate analysis of independent predicting risk factors
Independent predicting factors for GNB-HPS were a his-
tory of cancer (OR 57, 95% CI 2–1563, p = 0.018), and
only constitutional symptoms versus only back pain (OR
9, 95% CI 2.8–2666, p = 0.011) (Table 6). An independ-
ent predicting factor for GPC-HPS was epidural abscess
(OR 18, 95% CI 1.4–250, p = 0.027).
Discussion
Our results showed that compared with the 37 GPC-
HPS patients, the 17 GNB-HPS patients were more
likely to be older individuals with a history of cancer.
Chemotherapy/radiotherapy-induced alimentary mucosi-
tis occurs in patients treated for malignancy and the in-
sufficient mucosal barrier contributes to enteric bacterial
invasion and gram negative bacillary bacteremia with
organisms such as Escherichia coli, Klebsiella, and
Pseudomonas [9–12]. Numerous studies of bloodstream
infection in the elderly indicated that gram-negative
bacillary bacteremia was much more common in the
elderly than in younger patients because the common
infections in this population involve respiratory, urinary,
and gastrointestinal systems [13–16]. A retrospective
study of hematogenous vertebral osteomyelitis, con-
ducted by Park, et al. [6], demonstrated that UTI was
the main sources of infection in gram-negative vertebral
osteomyelitis. Consistent with those results, age and
UTI were significant factors for GNB-HPS in univariate
analysis but not statistically predicting factor in multi-
variate analysis. The contributing reason may be that the
incidence of cancer would increase with age and the
high prevalence of UTI was found among the elderly.
Based on initial symptoms at first visit, this study
showed that pain in the affected spinal region was the
most common manifestation in GPC-HPS patients
whereas constitutional symptoms (fever and drowsiness),
with or without back pain, was the primary reason for
initial physician visits in GNB-HPS patients. This latter
finding may be attributed to be the much older age and
frailty of our GNB-HPS patients. Clinical manifestations
of spinal infection in aging or immunocompromised pa-
tients with cancer or poor physical function may affect
their entire body with absence of localizing symptoms
[17]. These patients may present with poor appetite,
malaise, confusion, drowsiness, and fever. Therefore,
GNB-HPS patients, who are more likely to have the
early warning signs of drowsiness and fever, should seek
immediate medical attention as, in contrast to patients
with GPC infection, the majority of GNB-HPS patients
in our study had acute onset of symptoms.
In this study, GPC-HPS possessed a higher incidence of
epidural abscess formation than GNB-HPS. Staphylococcus
aureus employs virulence factors to promote abscess
formation [18, 19]. Similar to our findings, a comparative
study concerning hematogenous vertebral osteomyelitis
by GNB vs. methicillin-sensitive Staphylococcus aureus
(MSSA) showed that patients with MSSA hematogenous
vertebral osteomyelitis were more likely to have epidural
abscess, and CRP values were higher in MSSA infection [6].
The overall mortality rate of our HPS patients at
the 2-year follow-up was 14.8%, which is similar to
rates from previous studies which ranged from 1.5 to
Table 4 Findings of magnetic resonance imaging
Variable (No. [%]) GNB (n = 17) GPC (n = 37) p
Back muscle abscess 6 (35) 11 (30) 0.683
Epidural abscess 7 (41) 27 (73) 0.024*
Patient number in lumbar region n = 15 n = 30
Psoas muscle abscess 12 (80) 21 (70) 0.755
Single involvement 3 (25) 6 (29)
Bilateral involvement 9 (75) 15 (71)
*The difference is significant (p < 0.05)
Table 5 Laboratory data
Variable GNB (n = 17) GPC (n = 37) p
White blood cell count (103/uL) 13.1 ± 6.3 13.8 ± 4.8 0.656
Hemoglobin (g/dL) 11.0 ± 2.4 11.7 ± 2.6 0.372
C-reactive protein (mg/dL) 110 ± 57 162 ± 95 0.061
Erythrocyte sedimentation rate
(mm/h)
68.9 ± 31.2 84.3 ± 25.9 0.076
Bacteremia (No. [%]) 8 (47) 23 (62) 0.297
Table 6 Multivariate analysis of independent risk factors
Risk factor for GNB-HPS p value OR (95% CI)
Age 0.479
Symptoms at the initial visit 0.038*
Constitutional symptoms only/Back pain only 0.011* 9 (2.8–2666)
Malignancy 0.018* 57 (2–1563)
UTI 0.122
Risk factor for GPC-HPS
Epidural abscess 0.027* 18 (1.4–250)
*The difference is significant (p < 0.05)
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38% [1, 4, 6, 20, 21]. The large variance in these reported
mortality rates may be attributed to different follow-up
periods, varying in-hospital 6-month or 1-year mortality
rates, and different causative microorganisms such as
drug-resistant bacteria [6, 20, 21]. Park et al. reported an
in-hospital mortality rate of 10%, and the overall mortality
rate was 20% within 1-year follow-up [22]. Kehrer et al.
found that the mortality remained high in the first year
after admission [23].
To date, there are no evidence-based guidelines ad-
dressing the best treatment methods in the management
of pyogenic spondylodiscitis [24]. In review of literature,
the recommended duration of antibiotic therapy is from
6 weeks to 3 months, including a 2–8 week course of
intravenous antibiotics and a 6 week-3 month course of
oral antibiotics [24–26]. Although the mainstay of treat-
ment for spondylodiscitis is long-term antibiotic therapy
[25], surgical intervention is recommended in cases of
spinal instability with vertebral destruction, abscess for-
mation encroaching on psoas muscle or epidural spinal
canal, and neurologic deficits.
Our study had several limitations including the small
number of patients. Only a few patients were evaluated
because we restricted HPS to a definitive diagnosis based
on a microorganism isolated from the involved vertebrae
in order to avoid the negative impact of misdiagnosis on
the results. In addition, all patient data were collected
from the Spine Operation Registry and HPS patients
who received only antibiotic therapy were not included
in this study. Combined antibiotic and surgical treat-
ment was usually recommended in cases of deteriorated
vertebral pathologic destruction, paraspinal abscess for-
mation, and progressive sepsis. Although the characteris-
tics of our patients may not be fully representative of all
patients with HPS, the clinical features of patients in this
study were consistent with those reported in the cohort
studies of pyogenic spondylodiscitis, irrespective of
surgical treatment [6].
Conclusions
GNB-HPS patients were more likely to have a higher
prevalence of malignancy, and GPC-HPS patient had a
higher incidence of epidural abscess. GNB-HPS patients
had more-frequent constitutional symptoms and GPC-
HPS patients had predominant back pain. The clinical
outcomes of GNB-HPS patients under combined surgi-
cal and antibiotic treatment were not different from
those of GPC-HPS patients.
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